期刊
NEUROLOGY INDIA
卷 71, 期 -, 页码 S133-S139出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/0028-3886.373631
关键词
Endocrine; neurosurgery; pituitary adenoma; radiation oncology; radiosurgery
Pituitary adenomas are common benign brain tumors, comprising 10%-20% of all central nervous system neoplasms. Stereotactic radiosurgery (SRS) has emerged as an effective treatment option for these tumors, with high tumor control rates. However, potential side effects such as endocrine dysfunction and visual deficits need to be considered. Hypofractionated SRS, delivered in multiple fractions, is an alternative treatment option for patients who are not suitable for single fraction SRS.
Pituitary adenomas are benign brain tumors that comprise 10%-20% of all central nervous system neoplasms. In recent years, stereotactic radiosurgery (SRS) has emerged as a highly effective treatment option in the management of functioning and nonfunctioning adenomas. It is associated with tumor control rates frequently ranging from 80% to 90% in published reports. While permanent morbidity is uncommon, potential side effects include endocrine dysfunction, visual field deficits, and cranial nerve neuropathies. In patients where single fraction SRS would pose an unacceptable risk (e.g. large lesion size or close proximity to the optic apparatus), hypofractionated SRS delivered in 1-5 fractions is a potential treatment option; however, available data are limited. A comprehensive literature search of PubMed/MEDLINE, CINAHL, Embase, and the Cochrane Library was conducted to identify articles reporting on the use of SRS in functioning and nonfunctioning pituitary adenomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据